Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2024 | Rubedo Life Sciences | $40.0M Series A | Ahren Innovation Capital, Khosla Ventures | 7percent Ventures, Alumni Ventures, Catalio Capital, Gaingels, MarsBio, Moonstone Venture Capital, Presight Capital, Refactor Capital, SOSV, The House Fund, The Longevity Fund, Tiger Global Management, TLV Partners, Tuesday Capital, Amjad Masad, Andy Coravos, Anne Wojcicki, Balaji Srinivasan, Dan Ciporin, Dylan Field, Fidji Simo, Justin Mateen, Rich Miner, Varsha Rao, Hevolution, Italian Angels for Growth, LongeVC, Modi Ventures, R42 Group, Shanda Group |
| Apr 1, 2024 | Meridia | $6.0M Series A | — | Cerulean Ventures, Regeneration.VC, Edaphon, Intercontinental Exchange, Sabi Fund |